Cargando…

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1

BACKGROUND: The aim of this study was to determine the usefulness of placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in predicting the time for pregnancy termination in pregnant women with known preeclampsia (PE) onset. METHODS: Forty-four pregnant women diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Hiroaki, Tanaka, Kayo, Takakura, Sho, Enomoto, Naosuke, Ikeda, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251116/ https://www.ncbi.nlm.nih.gov/pubmed/35795634 http://dx.doi.org/10.3389/fmed.2022.900639

Ejemplares similares

Placental growth factor level is correlated with intrapartum fetal heart rate findings
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

The Successful Use of Nitroglycerin for Uterine Hyperstimulation with Fetal Heart Rate Abnormality Caused by a Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS): A Case Report
por: Takakura, Sho, et al.
Publicado: (2021)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
por: Souders, Colby A., et al.
Publicado: (2015)

Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling
por: Tanaka, Kayo, et al.
Publicado: (2022)

Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
por: Tsuchiya, Kyoka, et al.
Publicado: (2020)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia
por: Bian, Zheng, et al.
Publicado: (2015)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Miyatake, Risa, et al.
Publicado: (2023)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2020)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
por: Schlembach, Dietmar, et al.
Publicado: (2018)

Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia
por: Liu, Mei, et al.
Publicado: (2021)

Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
por: Velegrakis, Alexandros, et al.
Publicado: (2023)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2007)

Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia
por: Chen, Xinhua, et al.
Publicado: (2019)

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia—Systematic Review and Metanalysis
por: Marrufo-Gallegos, Karla Cecilia, et al.
Publicado: (2023)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Accurate evaluation of the progress of delivery with transperineal ultrasound may improve vaginal delivery: a single-center retrospective study
por: Enomoto, Naosuke, et al.
Publicado: (2023)

sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women With SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy
por: Hernandez-Pacheco, Jose Antonio, et al.
Publicado: (2022)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
por: Garrido-Giménez, Carmen, et al.
Publicado: (2023)

Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model
por: Venditti, Carolina C., et al.
Publicado: (2014)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
por: Klein, Evelyn, et al.
Publicado: (2016)

Association of sFlt-1 and C-reactive protein with outcomes in severe preeclampsia: A cohort study
por: Nóbrega, Leandro, et al.
Publicado: (2022)

sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
por: Giardini, Valentina, et al.
Publicado: (2023)

Appropriate Method of Administering Vasopressors for Maternal Hypotension Associated with Combined Spinal Epidural Anesthesia in Elective Cesarean Section: Impact on Postnatal Respiratory Support for Newborns
por: Magawa, Shoichi, et al.
Publicado: (2022)

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
por: Iriyama, Takayuki, et al.
Publicado: (2019)

Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model
por: Santana-Garrido, Álvaro, et al.
Publicado: (2022)

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
por: Maki, Shintaro, et al.
Publicado: (2020)

In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy
por: Szalai, Gabor, et al.
Publicado: (2014)

Correlation between 25-Hydroxyvitamin D, sFlt-1, PLGF, and Hypertension in Pregnancy
por: Wang, Wei, et al.
Publicado: (2021)

Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1–Induced Preeclampsia Phenotype in Mice
por: Zhang, Shenghong, et al.
Publicado: (2018)

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2019)

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
por: Saxena, Aditi R, et al.
Publicado: (2013)

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2018)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Pant, Vivek, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qvmjn6sbg2t9h2qnkohet9bod1